Related Experiment Video

Updated: Jun 11, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Chronic mucus hypersecretion: prevalence and risk factors in younger individuals

L Harmsen1, S F Thomsen, T Ingebrigtsen

  • 1Respiratory and Allergy Research Unit, Department of Respiratory Medicine L, Copenhagen University Hospital, Bispebjerg, Denmark. l.harmsen@dadlnet.dk

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|July 15, 2010
PubMed

Insights

Chronic mucus hypersecretion (CMH) affects young adults, particularly females. Asthma and smoking are key risk factors, with increased risk linked to higher tobacco consumption and younger age.

Area of Science:

  • Respiratory Medicine
  • Epidemiology
  • Genetics (Twin Studies)

Background:

  • Chronic mucus hypersecretion (CMH) is prevalent in chronic respiratory diseases.
  • Limited data exists on CMH incidence, prevalence, and determinants in younger populations.

Purpose of the Study:

  • To investigate the prevalence, incidence, and risk factors of CMH in a young general population.
  • To identify specific determinants associated with CMH development in adolescents and young adults.

Main Methods:

  • Prospective cohort study of Danish twins (aged 12-41 years) with questionnaire data from 1994 and 2002.
  • Prevalence and incidence of CMH were calculated.
  • Logistic regression analysis was used to assess risk factors.

Main Results:

  • Lifetime prevalence of CMH was 8.6% in females and 6.9% in males in 1994.
  • Cumulative incidence was 10.7% for females and 8.7% for males.
  • Smoking (with dose-response effect) and asthma were significant risk factors for CMH.

Conclusions:

  • CMH in young individuals is associated with asthma and smoking.
  • Tobacco consumption shows a dose-response relationship with CMH.
  • Females and younger individuals exhibited greater susceptibility to CMH.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation